VCI Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
VCI Wealth Management's DGX Position: Q2 2026 in Review
VCI Wealth Management increased its Quest Diagnostics (DGX) stake by 34% in Q2 2026, buying an estimated $584K and bringing the position to 11,636 shares worth $2.47M. The position accounts for 0.62% of the portfolio, ranked #44.
VCI Wealth Management first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- VCI Wealth Management held 11,636 shares of Quest Diagnostics worth $2.47M as of Q2 2026.
- VCI Wealth Management bought 2,974 Quest Diagnostics shares in Q2 2026, an estimated $584K.
- Quest Diagnostics made up 0.62% of VCI Wealth Management's portfolio in Q2 2026, its #44 holding.
- VCI Wealth Management first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
- 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on VCI Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.